Work

A pilot pharmacologic biomarker study of busulfan and fludarabine in hematopoietic cell transplant recipients

Year: 2011

Type: article

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-011-1736-3

Authors: Jeannine S. McCune, Erica L. Woodahl, Terry Furlong, Barry Storer, Joanne Wang, Shelly Heimfeld, H. Joachim Deeg, Paul V. O’Donnell

Institutions: University of Washington, Fred Hutch Cancer Center, University of Montana

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1125484814, G232612905, G2700895529, G2819971141, G30144808, Core Center of Excellence in Hematology, G4857603760, G6390593869, G87770821, Cancer Center Support Grant, Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge

OpenAlex ID: W1994119960

FWCI: 0.943

Cites: 34

Cited by: 21

Related to: 10